Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q2 2023 Earnings Call Transcript August 8, 2023
Iovance Biotherapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.47 EPS, expectations were $0.81.
Operator: Welcome to the Iovance Biotherapeutics’ Second Quarter 2023 Financial Results and Corporate Update Conference Call. My name is Shannon and I will be your operator for today’s call. At this time all participants are in a listen-only mode. Later we will conduct a...
